New in #HumPathol: Real-World HER2 Testing Practices and Performance of HER2 immunohistochemistry in Non-Breast, Non-Gastroesophageal Solid Tumors: Experience at a Large U.S. Academic Institution. https://t.co/nqAcevaFy8 #pathology#PathTwitter#PathX#IHCpath
New in #HumPathol: Prognostic significance and interobserver reproducibility of tumor budding and poorly differentiated clusters in primary duodenal adenocarcinoma. https://t.co/1lS3mbKCD4 #pathology#PathTwitter#PathX#GIpath
New in #HumPathol: Fusion partner dependent immunophenotype, chromoanagenesis, and prognosis in MEF2D-rearranged B-lymphoblastic leukemia. https://t.co/kFJdZnTSZt #pathology#PathTwitter#PathX#hemepath
New in #HumPathol: Clinicopathologic characteristics of gastric adenocarcinoma in autoimmune gastritis: Impact of Helicobacter pylori infection and diagnostic implications of multifocal disease. https://t.co/DRYALTR6K5 #pathology#PathTwitter#PathX#GIpath
New in #HumPathol: Do Clinical and Pathologic Differences Exist Between Hepatic Cavernous Hemangiomas Diagnosed Radiologically Versus Those Biopsied Due To Unclear Clinical Diagnosis? https://t.co/ylRAYpwefd #pathology#PathTwitter#PathX#liverpath
New in #HumPathol: Unusual Morphologic Variants of Solitary Fibrous Tumor: A Case Series of 17 Cases Featuring 10 Distinct Histomorphologies. https://t.co/76HyhUuFkS #pathology#PathTwitter#PathX#BSTpath
New in #HumPathol: Non-Conventional Histologic Components in Urothelial Carcinoma: Post-Neoadjuvant Chemotherapy Pathologic Outcomes in a Multi-institutional Radical Cystectomy Cohort. https://t.co/Ni3uaWEoap #pathology#PathTwitter#PathX#GUpath
New in #HumPathol: Routine prostate biopsy reports carry grade-specific tumor burden information beyond the highest Grade Group. https://t.co/2J5DT8Vcx2 #pathology#PathTwitter#PathX#GUpath
New in #HumPathol: Aberrant HER2 Expression as a Specific and Feasible Diagnostic Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma. https://t.co/o3wtHNHkSM #pathology#PathTwitter#PathX#GUpath
New in #HumPathol: Comprehensive Genomic Characterization of Primary Dermal Melanoma: Delineating it from Metastatic Melanoma with Unknown Primary. https://t.co/9sdBv13cJo #pathology#PathTwitter#PathX#dermpath
New in #HumPathol: Papillary Endothelial Hyperplasia in Late Post-Radiation or Late Post-Operative Breast Hematomas Mimicking Angiosarcoma. https://t.co/GGKuTactr7 #pathology#PathTwitter#PathX#breastpath
New in #HumPathol: Claudin 18.2 Immunohistochemistry in Gastroesophageal Adenocarcinomas: A Study of Interobserver Variability Among Gastrointestinal Pathologists. https://t.co/0FFz96mddB #pathology#PathTwitter#PathX#GIpath
New in #HumPathol: Spatial and Interlesional Heterogeneity of FGFR2b Expression in Paired Primary and Metastatic Gastric and Gastroesophageal Junction Adenocarcinomas. https://t.co/UX0L9HXtQs #pathology#PathTwitter#PathX#GIpath
New in #HumPathol: Expanding the clinicopathological spectrum of BAP1 mutated ccRCC: a study of 84 cases in multi-center cohort. https://t.co/6e0MSit4kT #pathology#PathTwitter#PathX#GUpath